CEO Interviews
Soligenix (NASDAQ: SNGX) CEO Interview
Significant NIH Funding and Two Pivotal Phase 3 Trials Ongoing […]
Significant NIH Funding and Two Pivotal Phase 3 Trials Ongoing […]
Interview with Randall White, CEO and president […]
Interview with Gary Weis, CEO […]
Interview with Max Porterfield, CEO […]
Interview with Michael Stein, CEO […]
Interview with Chris Buncic, CEO
Interview with Tony Di Benedetto, CEO […]
Interview with CEO Rick Van Kirk […]
Interview with CEO Martin Sumicharst […]
Interview with Jonathan Awde, CEO […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com